EARLY MOLECULAR SIGNATURES OF THERAPEUTIC RESPONSE TO VEDOLIZUMAB THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS IDENTIFIED USING A LONGITUDINAL MULTI-OMICS APPROACH

Nathan Baran  ¹     Neha Mishra     Konrad Aden  ²     Florian Tran  ³     Johanna Ira Blase     Claudio Conrad     Susanna Nikolaus  ⁴     Stefan Schreiber  ⁵     Philip Rosenstiel    
¹ Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany
² IKMB + First Medical Department, Kiel, Germany
³ University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
⁴ Univers.-Klinik Schleswig-Holstein, Kiel, Germany
⁵ University Hospital Schleswig-Holstein, Kiel, Germany

Topic
IBD, Immunology, Nurses

Session
Understanding the biology of therapeutic response in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)